A Phase II Trial of Weekly High-Dose Folinic Acid and 5-Fluorouracil in Combination with Epirubicin as Salvage Chemotherapy in Advanced Breast Cancer

Herbert Stöger,M. Schmid,Thomas Bauernhofer,Renate Moser,Ferdinand Ploner,Elke Derstvenscheg,Anne-Katrin Kasparek,I. Kuss,M. Wilders-Truschnig,Carolin Lackner,P. Steindorfer,Hellmut Samonigg

A Phase II Trial of Weekly High-Dose Folinic Acid and 5-Fluorouracil in Combination with Epirubicin as Salvage Chemotherapy in Advanced Breast Cancer

1994

Herbert Stöger
M. Schmid
Thomas Bauernhofer
Renate Moser
Ferdinand Ploner
Elke Derstvenscheg
Anne-Katrin Kasparek
I. Kuss
M. Wilders-Truschnig
Carolin Lackner
P. Steindorfer
Hellmut Samonigg

Twenty-five patients with advanced breast cancer (ABC) who had failed from first-line chemotherapy entered into a phase II study employing weekly 5-fluorouracil (FU) 350 mg/m2, folinic acid

Keywords:

Pathology
Fluorouracil
Breast cancer
Phases of clinical research
Oncology
Second-line therapy
Folinic acid
Side effect
Medicine
Epirubicin
Chemotherapy
Internal medicine
salvage treatment
Cancer
advanced breast

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations